Cosmetic compositions comprising sclareolide

Patent metadata

Field	Value
Publication number	US-10357447-B2
Application number	US-201615577073-A
Country	US
Kind code	B2
Filing date	May 25, 2016
Priority date	May 28, 2015
Publication date	Jul 23, 2019
Grant date	Jul 23, 2019

Abstract

Suggested is a cosmetic composition comprising an anti-pollution agent selected from the group consisting of sclareolide, ginger root CO2 extract, E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one, purple coneflower pressed juice or mixtures thereof, in a working amount sufficient for (a) reducing or preventing air pollution induced gene expression, and/or (b) reducing or preventing a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or (c) reducing or preventing air pollution-induced or air pollution-inducible skin damage.

First claim

The invention claimed is:

1. A method for protecting human skin and/or hair against air pollution induced damage by applying an effective amount of a composition consisting of an anti-pollution agent selected from the group consisting of
(i) sclareolide,
(ii) ginger root CO2 extract,
iii) E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one,
(iv) purple coneflower pressed juice,
binary mixtures thereof and ternary mixtures thereof,

wherein said agent is applied to human skin and/or hair in an effective amount of about 0.1 to about 5 mg/cm 2 , and wherein said composition is applied to an individual suffering from air pollution induced damage by
(a) an air pollution induced gene expression, and/or
(b) a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or
(c) an air pollution-induced or air pollution-inducible skin damage.

2. A method for protecting human skin and/or hair against air pollution induced damage by applying an effective amount of a composition comprising an anti-pollution agent selected from the group consisting of
(i) sclareolide,
(ii) ginger root CO2 extract,
iii) E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one,
(iv) purple coneflower pressed juice,
binary mixtures thereof and ternary mixtures thereof,

wherein said agent is applied to human skin and/or hair in an effective amount of about 2 to about 3 mg/cm 2 , and wherein said composition is applied to an individual suffering from air pollution induced damage by
(a) an air pollution induced gene expression, and/or
(b) a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or
(c) an air pollution-induced or air pollution-inducible skin damage.

3. A method for protecting human skin and/or hair against air pollution induced damage, comprising applying an effective amount of a binary mixture of
(i) sclareolide and ginger root CO2 extract, or
(ii) sclareolide and E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one, or
(iii) sclareolide and purple coneflower pressed juice,
as an AhR antagonist, and

wherein said composition is applied to an individual suffering from air pollution induced damage by
(a) an air pollution induced gene expression, and/or
(b) a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or
(c) an air pollution-induced or air pollution-inducible skin damage.

4. A method for protecting human skin and/or hair against air pollution induced damage, comprising applying an effective amount of a ternary mixture of
(i) sclareolide, ginger root CO2 extract and purple coneflower pressed juice; or
(ii) sclareolide, ginger root CO2 extract and E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one; or
(iii) sclareolide, E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one and purple coneflower pressed juice,
as an AhR antagonist, and wherein said composition is applied to an individual suffering from air pollution induced damage by
(a) an air pollution induced gene expression, and/or
(b) a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or
(c) an air pollution-induced or air pollution-inducible skin damage.

5. A method for protecting human skin and/or hair against air pollution induced damage by applying an effective amount of a composition comprising an anti-pollution agent selected from the group consisting of
(i) sclareolide,
(ii) ginger root CO2 extract,
(iii) E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one,
(iv) purple coneflower pressed juice,

binary mixtures thereof and ternary mixtures thereof,
wherein said composition is applied to an individual suffering from air pollution induced damage by
(a) an air pollution induced gene expression, and/or
(b) a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or
(c) an air pollution-induced or air pollution-inducible skin damage.

6. The method of claim 1 , comprising retarding induction of
(a) POMC gene, to protect skin cells against excessive melanin formation; and/or
(b) MMP1 (matrixmetalloproteinase-1) in the skin to protect the skin against increased formation of wrinkles; and/or
(c) IL-6 (interleukin-6) to protect skin cells against inflammation as well as pigment spot formation; and/or
(d) CYPA1 gene expression to protect skin cells against damage due to AhR activation.

7. The method of claim 3 , comprising retarding induction of
(a) POMC gene, to protect skin cells against excessive melanin formation; and/or
(b) MMP1 (matrixmetalloproteinase-1) in the skin to protect the skin against increased formation of wrinkles; and/or
(c) IL-6 (interleukin-6) to protect skin cells against inflammation as well as pigment spot formation; and/or
(d) CYPA1 gene expression to protect skin cells against damage due to AhR activation.

8. The method of claim 4 , comprising retarding induction of
(a) POMC gene, to protect skin cells against excessive melanin formation; and/or
(b) MMP1 (matrixmetalloproteinase-1) in the skin to protect the skin against increased formation of wrinkles; and/or
(c) IL-6 (interleukin-6) to protect skin cells against inflammation as well as pigment spot formation; and/or
(d) CYPA1 gene expression to protect skin cells against damage due to AhR activation.

9. The method of claim 2 , comprising retarding induction of
(a) POMC gene, to protect skin cells against excessive melanin formation; and/or
(b) MMPI (matrixmetalloproteinase-1) in the skin to protect the skin against increased formation of wrinkles; and/or
(c) IL-6 (interleukin-6) to protect skin cells against inflammation as well as pigment spot formation; and/or
(d) CYPA1 gene expression to protect skin cells against damage due to AhR activation.

Assignees

• Symrise Ag

Inventors

• Krutmann Jean
• Meyer Imke
• Johncock William
• Schmaus Gerhard
• Le Maire Marielle

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P17/00

  Drugs for dermatological disorders · CPC title

• A61Q17/00 Primary

  Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings · CPC title

• A61K8/9794

  Liliopsida [monocotyledons] · CPC title

• A61K8/9789 Primary

  Magnoliopsida [dicotyledons] · CPC title